Cyclosporin A specifically affects nuclear PLCbeta1 in immunodepressed heart transplant patients with gingival...

Area of Science:

• Pharmacology
• Cell Biology
• Oral Medicine

Background:

• Gingival overgrowth (GO) is a common adverse effect of cyclosporin A (CsA).
• Fibroblasts play a role in GO, but the reason for variable patient susceptibility is unknown.
• Previous research linked CsA to phospholipase C beta 1 (PLCbeta1) over-expression in fibroblasts of patients with GO.

Purpose of the Study:

• To investigate PLCbeta isoform expression in CsA-treated patients without clinical signs of GO.
• To determine if increased PLCbeta1 expression contributes to CsA-induced fibroblast hyper-responsiveness in patients without GO.
• To explore the multi-factorial origins of CsA-induced gingival overgrowth.

Main Methods:

• Assessed PLCbeta isoform expression in fibroblasts.
• Compared expression levels between patients with and without clinical signs of GO.
• Analyzed fibroblast response to CsA in vitro.

Main Results:

• Results suggest that specific gingival tissue changes may predispose fibroblasts to hyper-responsiveness.
• Increased PLCbeta1 expression might be a factor even in patients without visible GO.
• The study supports a multi-factorial etiology for CsA-induced gingival overgrowth.

Conclusions:

• Gingival overgrowth in response to CsA is likely multifactorial.
• Individual patient factors and cellular changes orchestrate fibroblastic hyper-responsiveness.
• Long-term CsA exposure may induce specific gingival tissue alterations contributing to GO.